| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd587c0c53d25f05a8d049cd446de8f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279753329e9e55653159266d71a9dd5b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1095 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3621 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958 |
| filingDate |
2010-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819ffa27269b7932b2a854d4fa8fa561 |
| publicationDate |
2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8322347-B2 |
| titleOfInvention |
Systems and methods for selective auto-retroperfusion of the cerebral venous system |
| abstract |
Methods for delivering a bridge retroperfusion therapy are disclosed such that, after the onset of a stroke or other adverse cerebral event, the brain cells' window of viability may be extended and other treatments, including pharmaceutical and neuroprotective therapies, may be more effectively utilized. Kits comprising devices and systems for delivering such retroperfusion and autoretroperfusion methods are also disclosed. In certain embodiments, the kits comprise a catheter and a flow unit configured to adjust the flow rate and pressure of the arterial blood used for perfusion of the venous system. |
| priorityDate |
2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |